retatrutide type 2 diabetes trial results π¨ Today, retatrutide, the GIP/GLP-1/glucagon triple agonist, just delivered TRIUMPH-2 top-line results. A study in those with concurrent obesity and diabetes. π Mean body weight change at 80 weeks: β¬οΈ Retatrutide Weight Loss Treatment Explained
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 10 - Aug 15


























